Navigation Links
OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation

orexigen.com/">http://www.orexigen.com.

Forward-Looking Statements

Orexigen cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Orexigen that any of its plans will be achieved. For example, statements regarding the potential progress and results of clinical trials and the use of funds to support such trials may be forward looking statements. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Orexigen's business, including, without limitation: Orexigen's clinical trials may not proceed in the timeframes or in the manner Orexigen expects or at all; the results of earlier clinical trials may not be predictive of future results; the scientific theories relating to the central nervous system on which Orexigen has based its development programs may not result in product candidates with sufficient efficacy or safety to obtain regulatory approval or commercial success; Orexigen and its licensors may not be able to obtain, maintain and successfully enforce adequate patent and other intellectual property protection of its product candidates; and other risks detailed in Orexigen's public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

     CONTACTS:

     Graham Cooper         Media:                        Investors:

     Orexigen CFO 
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
(Date:11/21/2014)... 21, 2014  Tandem Diabetes Care ® , ... device company and manufacturer of the t:slim ® ... Tidepool, a non-profit dedicated to improving diabetes therapy ... that increases diabetes data accessibility. This partnership will ... currently under development, to download and access data ...
(Date:11/21/2014)... SAN MARCOS, Texas , Nov. 21, 2014 /PRNewswire/ ... industrial hemp containing low THC, announces they are now ... is comparable to Charlotte,s Web type strains grown in ... symptoms from other neurological disorders, such as Parkinson,s, MS, ... waiting for US laws to pass, because imported CBD ...
Breaking Medicine Technology:Alere Appoints Juliet Cunningham to Lead Investor Relations 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3
... The U.S. Food and Drug Administration today approved Soliris ... (aHUS), a rare and chronic blood disease that can ... with increased risk of death and stroke. ... HUS accounts for 5 to 10 percent of all ...
... Internal Fixation Systems, Inc. (OTC QB: IFIX), manufacturer ... podiatric implants announced today that the company has been ...  DTC eligibility allows ownership of the company,s shares to ... Depository Trust Company is a member of the U.S. ...
Cached Medicine Technology:FDA Approves Soliris for Rare Pediatric Blood Disorder 2FDA Approves Soliris for Rare Pediatric Blood Disorder 3Internal Fixation Systems, Inc. Announces DTC Eligibility 2
(Date:11/23/2014)... 2014 Asher Milgrom, is a ... Wellness was recently featured on International Business ... and CEO of American Medical Aesthetics & Wellness, also ... a full scholarship to attend an M.D./Ph.D program at ... the University of Chicago, where his field of study ...
(Date:11/23/2014)... OH (PRWEB) November 23, 2014 Syngenta ... LLC on behalf of farmers and agribusinesses that have ... attempts to commercialize Agrisure Viptera and Agrisure Duracade, ... not been approved for sale in China. According to ... China to virtually ban U.S. corn imports. Because China ...
(Date:11/23/2014)... City, Utah (PRWEB) November 23, 2014 ... health insurance reimbursement for small businesses, announced their ... book, The End of Employer-Provided Health Insurance. ... insurance is the greatest financial risk facing most ... facing U.S. employers, small and large, when it ...
(Date:11/22/2014)... Cancer researchers in New York and Minnesota ... tunnels and the growth and spread of mesothelioma. ... the Surviving Mesothelioma website. , Doctors at Memorial ... have just released their study on tunneling nanotubes (TnTs), ... They found that mesothelioma cells contain many ...
(Date:11/22/2014)... A classic black prom dress will never go out of ... unveiled its new items of black prom gowns . ... big discount, up to 70% off. People throughout the world ... prom dresses, made with the best materials, can make wearers ... customers, the company provides these beautiful outfits in a huge ...
Breaking Medicine News(10 mins):Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:New Black Prom Dresses from BellasDress.com 2
... Service (ARS) finds that various forms of peanut flour ... to help food experts to improve food textures. ... oil from roasted peanut seeds. It is added to ... dressings to enhance flavor and protein value. ...
... American client who wants to show it in Tokyo in ... all this from Chennai too! ,But a small company ... Specialising in providing software services to the healthcare sector, it ... in millions of dollars in profit. ,Its ...
... in effectiveness to each other but differ when it ... released today by HHS’ Agency for Healthcare Research and ... of nearly 300 published studies of second-generation antidepressants, show ... relief from the drugs. About six in 10 also ...
... that too much alcohol can lead to multiple health ... of this perception.// Many people also assume that a ... probably alcoholics. This may not be accurate. A recent ... that, in fact, most alcohol-related problems may be due ...
... the bacterium that causes pneumonic plague is significantly slowed when ... Washington University School of// Medicine in St. Louis report in ... a primary concern in pneumonic plague, which kills in three ... terrorist attack. The bacterium that causes plague, Yersinia pestis, is ...
... (MS) is a chronic inflammatory disorder that causes degeneration ... leading to various symptoms including muscle// weakness and pain. ... cycles of disease and remission, leading to the suggestion ... inflammation. Using a mouse model of MS (known as ...
Cached Medicine News:Health News:Cashing in on IT for Healthcare 2Health News:Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ 2Health News:Newer Class of Antidepressants Similar in Effectiveness, Side Effects Differ 3Health News:Excessive Drinking, Not Alcoholism, may Lead to Most Alcohol-Related Problems 2Health News:Disabling Key Protein may Give Physicians Time to Treat Pneumonic Plague 2
... efficiency by reducing errors and eliminating costly ... solution, you can spend less time on ... more time on your patient care. Cardiology ... solution. With over 50,000 installations and a ...
... PrimeSuite, is a Web Browser-based Ambulatory ... Management, Electronic Medical Record (EMR) and ... the healthcare industrys demand for dependable ... of a suite of physician-centric software ...
... the Point-of Care Electronic Medical Record portion ... encounter documentation process and electronic patient record ... that is both mobile and secure. Using ... as pentop technology with a stylus device, ...
... EMR family of products offers complete ... of specialties. Intuition EMR enables physicians ... electronic record at the point of ... less time on documentation and more ...
Medicine Products: